Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 ,inter alia, to consider and approve Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed BSE that its Board of Directors will meet on Friday, May 9, 2025, at 12:00 PM. The key item on the agenda is to consider and approve the Audited Standalone Financial Results for the full year and quarter ended March 31, 2025 (i.e., FY25 results and Q4 FY25). The company has also confirmed that the trading window for its securities remains closed for all designated persons from April 1, 2025, until May 11, 2025 — 48 hours after the results are approved — as per insider trading norms. The intimation is filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, 2015. No financial numbers or business details have been shared in this filing.
This is a routine procedural filing with no direct impact on the stock price. Investors should watch the actual audited results on May 9 for any meaningful read on the company's FY25 performance, as the figures themselves will be the real catalyst.